No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10828545 |
chr10:18629603-18629604 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
CpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs541145429 |
chr10:18629663-18629664 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs182634399 |
chr10:18629672-18629673 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs556131650 |
chr10:18629682-18629683 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs551335125 |
chr10:18629692-18629693 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs557805225 |
chr10:18629695-18629696 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs186962230 |
chr10:18629707-18629708 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs114519689 |
chr10:18629778-18629779 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs550258909 |
chr10:18629836-18629837 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs369696287 |
chr10:18629852-18629853 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs374233500 |
chr10:18629885-18629886 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs12266692 |
chr10:18629886-18629887 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs377533233 |
chr10:18629915-18629916 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs530723634 |
chr10:18629928-18629929 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs191227810 |
chr10:18629940-18629941 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs146042014 |
chr10:18629941-18629942 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs201816240 |
chr10:18629946-18629947 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs547845807 |
chr10:18629999-18630000 |
Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs184120039 |
chr10:18630003-18630004 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs540011648 |
chr10:18630149-18630150 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs527849410 |
chr10:18630154-18630155 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146363841 |
chr10:18630162-18630163 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs138372212 |
chr10:18630176-18630177 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs550509179 |
chr10:18630201-18630202 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs142860244 |
chr10:18630210-18630211 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs576177959 |
chr10:18630243-18630244 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs538588827 |
chr10:18630285-18630286 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs144267613 |
chr10:18630351-18630352 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs540699894 |
chr10:18630391-18630392 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs188673689 |
chr10:18630423-18630424 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs577705892 |
chr10:18630424-18630425 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs545149887 |
chr10:18630434-18630435 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs193233995 |
chr10:18630435-18630436 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs78794602 |
chr10:18630481-18630482 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs185311761 |
chr10:18630497-18630498 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs12573736 |
chr10:18630649-18630650 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs529246083 |
chr10:18630657-18630658 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs547513592 |
chr10:18630678-18630679 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs566123335 |
chr10:18630684-18630685 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs188907024 |
chr10:18630734-18630735 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs374109979 |
chr10:18630764-18630765 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs558791735 |
chr10:18630784-18630785 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs537678360 |
chr10:18630802-18630803 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs556077572 |
chr10:18630846-18630847 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs574434426 |
chr10:18630869-18630870 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs539256700 |
chr10:18630872-18630873 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs10458703 |
chr10:18630884-18630885 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs552704764 |
chr10:18630900-18630901 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs376631221 |
chr10:18630948-18630949 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs191871490 |
chr10:18631002-18631003 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|